Our TB-500 monograph covers its pharmacology in more detail
Among users of both semaglutide and tirzepatide, the study details that 36.9% reported nausea, 16.7% fatigue, 16.3% vomiting, 15.3% constipation, and 12.6% diarrhea
Clinical Dermatology, St
After that date, chemical stability cannot be guaranteed, and the medication may be less effective or unsafe
Some may notice their appetite changing within the first few weeks, while others may start seeing weight loss by the first month, with overall results typically happening over the first year of treatment
Rarely, mild nausea (more commonly discussed when administered on an empty stomach in some protocols)